The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Prevention of Lysosomal Storage in Tay-Sachs Mice Treated with N -Butyldeoxynojirimycin
Abstract
The glycosphingolipid (GSL) lysosomal storage diseases result from the inheritance of defects in the genes encoding the enzymes required for catabolism of GSLs within lysosomes. A strategy for the treatment of these diseases, based on an inhibitor of GSL biosynthesis N -butyldeoxynojirimycin, was evaluated in a mouse model of Tay-Sachs disease. When Tay-Sachs mice were treated with N -butyldeoxynojirimycin, the accumulation of G M2 in the brain was prevented, with the number of storage neurons and the quantity of ganglioside stored per cell markedly reduced. Thus, limiting the biosynthesis of the substrate (G M2 ) for the defective enzyme (β-hexosaminidase A) prevents GSL accumulation and the neuropathology associated with its lysosomal storage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barton, N. W., Brady, R. O., Dambrosia, J. M., Di Bisceglie, A. M., Doppelt, S. H., Hill, S. C., Mankin, H. J., Murray, G. J., Parker, R. I., Argoff, C. E., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105233242104 · Cited by 1,252
Neufeld, E. F. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.001353 · Cited by 900
Pastores, G. M. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00036-6 · Cited by 633
Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-170 · Cited by 468
Self-citationN-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.
Platt, F. M., Neises, G. R., Dwek, R. A., & Butters, T. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37202-2 · Cited by 455
Self-citationYamanaka, S., Johnson, M. D., Grinberg, A., Westphal, H., Crawley, J. N., Taniike, M., Suzuki, K., & Proia, R. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9975 · Cited by 209
Self-citationGaucher Disease: New Molecular Approaches to Diagnosis and Treatment
Beutler, E. (1992) · Science · doi:10.1126/science.256.5058.794 · Cited by 188
Enzyme replacement therapy for Gaucher disease
Beutler, E., Kay, A., Saven, A., Garver, P., Thurston, D., Dawson, A., & Rosenbloom, B. (1991) · Blood · doi:10.1182/blood.v78.5.1183.1183 · Cited by 169
Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease
Taniike, M., Yamanaka, S., Proia, R. L., Langaman, C., Bone-Turrentine, T., & Suzuki, K. (1995) · Acta Neuropathologica · doi:10.1007/bf00309622 · Cited by 82
Self-citationInhibitors of Glycosphingolipid Biosynthesis.
Platt, F. M., & Butters, T. D. (1995) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.7.495 · Cited by 37
Self-citation
Cited by
Bertozzi, C. R., & Kiessling, A. L. L. (2001) · Science · doi:10.1126/science.1059820 · Cited by 1,939
Asano, N., Nash, R. J., Molyneux, R. J., & Fleet, G. W. J. (2000) · Tetrahedron: Asymmetry · doi:10.1016/s0957-4166(00)00113-0 · Cited by 1,015
Cu-Catalyzed Click Reaction in Carbohydrate Chemistry
Tiwari, V. K., Mishra, B. B., Mishra, K. B., Mishra, N., Singh, A. S., & Chen, X. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00408 · Cited by 862
The cell biology of lysosomal storage disorders
Futerman, A. H., & van Meer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1423 · Cited by 796
Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebícek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02161-9 · Cited by 744
Self-citationPolyhydroxylated alkaloids—Natural occurrence and therapeutic applications
Watson, A. A., Fleet, G. W. J., Asano, N., Molyneux, R. J., & Nash, R. J. (2001) · Phytochemistry · doi:10.1016/s0031-9422(00)00451-9 · Cited by 714
Cu(I)-Catalyzed Click Chemistry in Glycoscience and Their Diverse Applications
Agrahari, A. K., Bose, P., Jaiswal, M. K., Rajkhowa, S., Singh, A. S., Hotha, S., Mishra, N., & Tiwari, V. K. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00920 · Cited by 472
Physiology and pathophysiology of sphingolipid metabolism and signaling
Huwiler, A., Kolter, T., Pfeilschifter, J., & Sandhoff, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00042-1 · Cited by 432
Targeting glycosylation as a therapeutic approach
Dwek, R. A., Butters, T. D., Platt, F. M., & Zitzmann, N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd708 · Cited by 420
Self-citationSphingolipid metabolism diseases
Kolter, T., & Sandhoff, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.027 · Cited by 367
Critical role for glycosphingolipids in Niemann-Pick disease type C
Zervas, M., Somers, K. L., Thrall, M. A., & Walkley, S. U. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00396-7 · Cited by 324
The Organizing Potential of Sphingolipids in Intracellular Membrane Transport
Holthuis, J. C. M., Pomorski, T., Raggers, R. J., Sprong, H., & Van Meer, G. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1689 · Cited by 320
Vellodi, A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05293.x · Cited by 295
Inhibition of Glycosphingolipid Biosynthesis: Application to Lysosomal Storage Disorders
Butters, T. D., Dwek, R. A., & Platt, F. M. (2000) · Chemical Reviews · doi:10.1021/cr990292q · Cited by 292
Self-citationGaucher disease: pathological mechanisms and modern management
Jmoudiak, M., & Futerman, A. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05351.x · Cited by 288
Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease
Lee, J.-P., Jeyakumar, M., Gonzalez, R., Takahashi, H., Lee, P.-J., Baek, R. C., Clark, D., Rose, H., Fu, G., Clarke, J., et al. (2007) · Nature Medicine · doi:10.1038/nm1548 · Cited by 287
Self-citationKrivit, W., Peters, C., & Shapiro, E. G. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199904000-00007 · Cited by 273
Jeyakumar, M., Butters, T. D., Cortina-Borja, M., Hunnam, V., Proia, R. L., Perry, V. H., Dwek, R. A., & Platt, F. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6388 · Cited by 267
Self-citationChemical chaperone therapy for brain pathology in G M1 -gangliosidosis
Matsuda, J., Suzuki, O., Oshima, A., Yamamoto, Y., Noguchi, A., Takimoto, K., Itoh, M., Matsuzaki, Y., Yasuda, Y., Ogawa, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536657100 · Cited by 262
Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders
Coutinho, M., Santos, J., & Alves, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071065 · Cited by 116
Metadata
- Authors
- Platt, F. M., Neises, G. R., Reinkensmeier, G., Townsend, M. J., Perry, V. H., Proia, R. L., Winchester, B., Dwek, R. A., & Butters, T. D.
- Venue
- Science
- Published
- 1997-04-18
- Volume
- 276
- Issue
- 5311
- Pages
- 428-431
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2032826794
- Cited by
- 340
- References
- 10
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.